anti-TGF-betaR2 Ab (Elli Lilly)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-TGF-betaR2 Ab (Elli Lilly)
Drug Alias Nameanti-TGF-beta-receptor II mAb (Eli Lilly)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTransforming growth factor beta receptor 2 inhibitors
TargetsTransforming growth factor beta receptor 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A